Indrani L. Franchini, J.D.

Indrani L. Franchini, J.D.

Executive Vice President, Chief Legal OfficeratAlnylam Pharmaceuticals· In proxies 2022–2023

Pay in FY2023-64% from the year before · Alnylam Pharmaceuticals stock -19.5% the same year

Indrani L. Franchini, J.D. was paid $2.0M in FY2023 (Dec), down 64%. Alnylam Pharmaceuticals stock fell 19.5% that year.

Pay$100 in the stock at the end of FY21 → $113
Pay is from the Summary Compensation Table of each Alnylam Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Alnylam PharmaceuticalsPublic company · 4 yr
    • Executive Vice President, Chief Legal Officer2022 – Present · 4 yrStock in role +44%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?